Clinical Trial Update: Ex-Vivo Reversion of Platelet Inhibition Induced by Prasugrel

View source ↗

Summary

A completed clinical trial evaluated strategies to reverse prasugrel-induced platelet inhibition ex vivo in patients with an acquired platelet disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Platelet Disorder

Drugs mentioned

• PRASUGREL (prasugrel)

Snippet

Sponsor: University Hospital, Geneva | Conditions: Acquired Platelet Disorder | Status: COMPLETED